Opinion: A truce in the stem cell wars?
By Richard Hayes,
San Francisco Examiner
| 11. 24. 2006
The contentious midterm elections clearly left a mark on the politics of stem cell research, but it’s not clear what the mark signifies. Missouri’s closely watched stem cell initiative barely squeaked by with 51 per cent of the vote, despite a $30 million campaign financed almost entirely by a single wealthy couple. And in nine congressional races identified as high priority by stem cell research advocates, the stem cell candidate won in only four.
At the same time, at least 60 percent of all races in which stem cell research was an issue — including high-profile races for Congress, the Senate, and governorships — were won by the candidate supporting the research. And there’s no denying the frenzied TV and YouTube campaigning by partisans on all sides reinforced the identity of "stem cells" as an iconic trope of the culture wars.
Incoming Democratic House Speaker Nancy Pelosi has pledged a vote on federal stem cell funding "within the first 100 hours" of the new Congress. It appears there are now enough votes in the Senate to override a presidential veto...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
By Eric Schmidt, TIME | 04.16.2024
Imagine a world where everything from plastics to concrete is produced from biomass. Personalized cell and gene therapies prevent pandemics and treat previously incurable genetic diseases. Meat is lab-grown; enhanced nutrient grains are climate-resistant. This is what the future could...
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...